罗氏眼科药Vabysmo拖累二季度销售
2026-07-23 05:59:14
据彭博社报道，罗氏控股第二季度销售受到明星眼科药Vabysmo拖累，复苏速度慢于预期。投资者正寄望一款关键新药推动其后续增长。
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
币安将支持Polygon（POL）网络升级及硬分叉Next article：
HSBC Cuts NetEase Price Target to $150 From $162
